Clinical trial
Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
NCT01910220 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)
- Lead sponsor
- Regeneron Pharmaceuticals
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- October 31, 2014
- Enrollment
- 125 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
healthy volunteers